(1997) High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells
It directly determines whether the compound you're considering is appropriate for your goal, your body, and your risk tolerance
Research in Sports Medicine, 28(3), 342-355
The FDAs position is unambiguous: BPC-157 "lacks sufficient safety data and has not been shown to be safe or effective in humans." Key implications: Compounding pharmacies cannot legally compound medications containing BPC-157 under Section 503A or 503B Marketing with therapeutic claims violates federal law regardless of disclaimers Warning letters have been issued to companies marketing BPC-157 as a therapeutic agent WADA Prohibition The World Anti-Doping Agency classifies BPC-157 as a prohibited substance under class S0: Non-Approved Substances , effective January 2023
Severe deficiency can cause deep depression, paranoia, delusions, incontinence, loss of taste and smell, and other neurological damage
Travel Smarter